HHGA
WST icon

Halbert Hargrove Global Advisors’s West Pharmaceutical WST Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464 Buy
+1
New +$306 ﹤0.01% 542
2025
Q4 		– Sell
-13
Closed -$3.41K – 749
2025
Q3 		$3.41K Buy
+13
New +$3.16K ﹤0.01% 478
2025
Q2 		– Sell
-1
Closed -$224 – 669
2025
Q1 		$224 Buy
+1
New +$276 ﹤0.01% 584

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Halbert Hargrove Global Advisors's WST Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in West Pharmaceutical (WST) in Q2 2026: 1 share worth $464. The stake represents ﹤0.01% of the portfolio and ranks #542 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in WST as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in WST in Q1 2025 and has held it in 3 quarters since. The position peaked at $3.41K in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Halbert Hargrove Global Advisors held 1 share of West Pharmaceutical worth $464 as of Q2 2026.
  • West Pharmaceutical was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #542 holding.
  • Halbert Hargrove Global Advisors first reported a position in West Pharmaceutical in Q1 2025 and has held it in 3 quarters since.
  • Halbert Hargrove Global Advisors's West Pharmaceutical position peaked at $3.41K in Q3 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.